Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

85.40
+0.47000.55%
Pre-market: 84.75-0.6500-0.76%06:10 EDT
Volume:690.93K
Turnover:58.44M
Market Cap:6.97B
PE:-23.14
High:85.65
Open:82.78
Low:82.67
Close:84.93
52wk High:103.00
52wk Low:19.45
Shares:81.64M
Float Shares:54.63M
Volume Ratio:0.86
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6900
EPS(LYR):-3.6900
ROE:-25.78%
ROA:-15.87%
PB:4.41
PE(LYR):-23.14

Loading ...

Kymera Therapeutics Inc - KT-621 Phase 2B Ad Trial Data Expected by Mid-2027

THOMSON REUTERS
·
Dec 11, 2025

Kymera Therapeutics Inc : Mizuho Raises Target Price to $120 From $81

THOMSON REUTERS
·
Dec 11, 2025

Kymera Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
Dec 11, 2025

BRIEF-Kymera Therapeutics Announces Pricing Of Upsized $602 Million Public Offering At $86 Per Share

Reuters
·
Dec 10, 2025

Kymera Therapeutics Inc - Selling 7,000,000 Shares at $86 per Share

THOMSON REUTERS
·
Dec 10, 2025

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering

THOMSON REUTERS
·
Dec 10, 2025

Kymera Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $134 From $84

THOMSON REUTERS
·
Dec 09, 2025

Kymera Therapeutics Shares Down 3.9% Premarket After Climbing 41.5% in Previous Session

THOMSON REUTERS
·
Dec 09, 2025

Kymera Therapeutics : Oppenheimer Raises Target Price to $120 From $67

THOMSON REUTERS
·
Dec 09, 2025

Truist Securities Adjusts Kymera Therapeutics PT to $116 From $80, Maintains Buy Rating

MT Newswires Live
·
Dec 09, 2025

Kymera Therapeutics Inc : Truist Securities Raises Target Price to $116 From $80

THOMSON REUTERS
·
Dec 09, 2025

Kymera Therapeutics Inc : Bofa Global Research Raises Price Objective to $112 From $71

THOMSON REUTERS
·
Dec 09, 2025

Morgan Stanley Raises Price Target on Kymera Therapeutics to $127 From $73, Keeps Overweight Rating

MT Newswires Live
·
Dec 09, 2025

Kymera Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
Dec 09, 2025

Kymera Therapeutics CEO Nello Mainolfi Reports Disposal of Common Shares

Reuters
·
Dec 09, 2025

Kymera Therapeutics Launches Public Offering of Common Shares

MT Newswires Live
·
Dec 09, 2025

Press Release: Kymera Therapeutics Announces Proposed Public Offering

Dow Jones
·
Dec 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart

Reuters
·
Dec 09, 2025

These Stocks Are Moving the Most Today: Warner Bros., Netflix, Tesla, Confluent, Kymera, Marvell, Carvana, and More -- Barrons.com

Dow Jones
·
Dec 08, 2025

Market Movers | Wave Life Sciences Rockets 100%; Kymera Therapeutics Soars 48%; Carvana, DXYZ Jump 8% Each; CoreWeave Falls 5%

Tiger Newspress
·
Dec 08, 2025